Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease — Stella

Home/Thyroid Eye Disease (TED)/

View on ClinicalTrials.gov

Recruiting

Back to Thyroid Eye Disease (TED) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Phase

Large-scale testing

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd

Enrollment target

~258 participants

Started

January 2026

Primary completion

January 2029

Age range

18 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.